AnGes, Inc. (TYO:4563)
Japan · Delayed Price · Currency is JPY 39.00
0.00 (0.00%)
Aug 27, 2026, 11:04 AM JST
AnGes Market Cap
AnGes has a market cap or net worth of 15.55 billion as of August 26, 2026. Its market cap has decreased by -54.33% in one year.
Market Cap
15.55B
Enterprise Value
16.00B
Revenue
962.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
39.00
ChartMarket Cap Chart
Since September 25, 2002, AnGes's market cap has decreased from 23.36B to 15.55B, a decrease of -33.41%. That is a compound annual growth rate of -1.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 15.55B | -34.20% |
| Dec 30, 2025 | 23.64B | 57.68% |
| Dec 30, 2024 | 14.99B | 5.37% |
| Dec 29, 2023 | 14.23B | -31.96% |
| Dec 30, 2022 | 20.91B | -64.42% |
| Dec 30, 2021 | 58.78B | -64.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemRIM | 22.38B |
| Renascience | 17.94B |
| CanBas | 15.33B |
| RaQualia Pharma | 14.71B |
| ReproCELL | 14.69B |
| Stella Pharma | 12.50B |
| Kubota Pharmaceutical Holdings | 11.03B |
| Immuno-Biological Laboratories | 10.06B |